Natco Pharma Limited Approves Interim Dividend for the Year 2015-2016; Approves Appointment of S. V. V. N. Appa Rao as Chief Financial Officer
The company also approved Interim CFO Mr. S. V. V. N. Appa Rao appointed as Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
982.9 INR | -0.71% | -0.21% | +21.14% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
1st Jan change | Capi. | |
---|---|---|
+21.14% | 2.12B | |
+31.87% | 588B | |
-3.12% | 364B | |
+19.35% | 326B | |
+4.70% | 285B | |
+15.28% | 239B | |
+10.26% | 210B | |
-7.28% | 200B | |
+8.96% | 167B | |
-0.45% | 161B |